White Coat, Masked Hypertensives Could Win Ambulatory Blood Pressure Monitoring Coverage Under CMS Proposal

An April 9 proposed decision memo from the US Centers for Medicare and Medicaid Services would allow additional coverage for use of ambulatory blood pressure monitoring (APBM) devices by Medicare beneficiaries with known or suspected high blood pressure who meet specific criteria defined by the agency.

Medical concept

The Centers for Medicare and Medicaid Services says it's reasonable and necessary for some Medicare beneficiaries to be covered for ambulatory blood pressure monitoring (APBM) for diagnostic and management purposes, and laid out its logic for doing so in a proposed decision memo released on April 9.

Under the proposed decision memo, ABPM devices could be used for beneficiaries with suspected white coat hypertension (high blood...

More from Policy & Regulation

More from Medtech Insight